Usefulness of ultrasonographic measurement of the diameter of the inferior vena cava to predict responsiveness to intravascular fluid administration in patients with cancer.
We conducted an observational, longitudinal prospective study in which we measured the diameters of the inferior vena cava (IVC) of 47 patients using ultrasonography. The aim of our study was to assess the state of blood volume and to determine the percentage of patients who responded to intravascular volume expansion. Only 17 patients (36%) responded to fluid management. A higher number of responding patients had cardiovascular failure compared with nonresponders (82% vs. 50%,P= 0.03). Among the patients with cardiovascular failure, the probability of finding responders was 4.6 times higher than that of not finding responders (odds ratio, 4.66; 95% confidence interval, 1.10-19.6;P= 0.04). No significant difference was observed in the mortality rate between the two groups (11% vs. 23%,P= 0.46). In conclusion, responding to intravascular volume expansion had no impact on patient survival in the intensive care unit.
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Silvio A
SA
Ñamendys-Silva
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Juan M
JM
Arredondo-Armenta
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Humberto
H
Guevara-García
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Mireya
M
Barragán-Dessavre
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Francisco J
FJ
García-Guillén
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Luis A
LA
Sánchez-Hurtado
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Bertha
B
Córdova-Sánchez
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Andoreni R
AR
Bautista-Ocampo
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Angel
A
Herrera-Gómez
Department of Critical Care Medicine, Instituto Nacional de Cancerología, México (Ñamendys-Silva, Arredondo-Armenta, Guevara-García, Barragán-Dessavre, García-Guillén, Sánchez-Hurtado, Córdova-Sánchez, Bautista-Ocampo, Herrera-Gómez, Meneses-García); Department of Critical Care Medicine, Fundación Clínica Médica Sur, Ciudad de México (Ñamendys-Silva, Arredondo-Armenta, Barragán-Dessavre); and Department of Critical Care Medicine, Hospital de Especialidades Centro Médico Nacional La Raza, Mexican Institute of Social Security, Mexico City, Mexico (Sánchez-Hurtado).
Abelardo
A
Meneses-García
New Horiz. 1997 Aug;5(3):201-6
9259331
Crit Care Med. 1984 Feb;12(2):107-12
6697726
Curr Opin Crit Care. 2007 Oct;13(5):549-53
17762234
Crit Care Med. 1998 Nov;26(11):1793-800
9824069
Braz J Med Biol Res. 2013 Feb;46(2):186-93
23369978
Crit Care Med. 2011 Feb;39(2):259-65
20975548
Intensive Care Med. 2007 Jul;33(7):1125-32
17508199
Crit Care. 2012 Oct 08;16(5):R188
23043910
N Engl J Med. 1983 Feb 3;308(5):263-7
6848938
Chest. 2002 Jun;121(6):2000-8
12065368
Intensive Care Med. 1996 Jul;22(7):707-10
8844239
Crit Care Med. 2009 Sep;37(9):2642-7
19602972
Chest. 2007 Dec;132(6):2020-9
18079239
BMJ. 2006 Nov 4;333(7575):930-1
17082525
JAMA. 1999 Mar 17;281(11):1022-9
10086438
Crit Care Med. 1985 Oct;13(10):818-29
3928249